{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:07:22Z","timestamp":1793902042738,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bbmt.2019.05.036","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T12:08:36Z","timestamp":1559822916000},"page":"1898-1907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"25","author":[{"given":"Yanmin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.05.036_bib0001","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00277-015-2440-x","article-title":"The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation","volume":"94","author":"Sun","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0002","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2016-03-702803","article-title":"Atorvastatin enhances endothelial cell function in posttransplant poor graft function","volume":"128","author":"Shi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0003","first-page":"112","article-title":"CD34+-selected stem cell \u201cBoost\u201d for poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Mohty","year":"2019","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0004","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbmt.2010.02.013","article-title":"Second unrelated donor hematopoietic cell transplantation for primary graft failure","volume":"16","author":"Schriber","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0005","first-page":"935","article-title":"Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation","volume":"91","author":"Larocca","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0006","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s003300000528","article-title":"Radiology of the spleen","volume":"11","author":"Robertson","year":"2001","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0007","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood-2014-04-571570","article-title":"T-cell-replete haploidentical HSCT with low-dose anti-T lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT","volume":"124","author":"Luo","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0008","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MAJ.0000000000000186","article-title":"Second-generation tyrosine kinase inhibitors combined with stem cell transplantation in patients with imatinib-refractory chronic myeloid leukemia","volume":"347","author":"Zhao","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0009","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.bmt.1704428","article-title":"Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation\u2014frequency and outcomes","volume":"33","author":"Lee","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0011","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2141.2001.02468.x","article-title":"Factors influencing haematologcal recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose","volume":"112","author":"Dominietto","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0012","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/bjh.15012","article-title":"CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation","volume":"180","author":"Mainardi","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0013","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00432-015-2027-x","article-title":"Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation","volume":"141","author":"Haen","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0014","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbmt.2013.11.034","article-title":"CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies","volume":"20","author":"Klyuchnikov","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/14653240600735784","article-title":"CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation","volume":"8","author":"Oyekunle","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0016","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.beha.2004.10.003","article-title":"LPI-labile plasma iron in iron overload","volume":"18","author":"Cabantchik","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0018","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12185-011-0988-3","article-title":"The effect of iron overload and chelation on erythroid differentiation","volume":"95","author":"Taoka","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0019","doi-asserted-by":"crossref","first-page":"30892","DOI":"10.18632\/oncotarget.8810","article-title":"Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants","volume":"7","author":"Kong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/bmt.2017.93","article-title":"Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection","volume":"52","author":"Ohmoto","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0021","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.leukres.2009.10.028","article-title":"Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation","volume":"34","author":"Lim","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0022","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbagen.2008.07.002","article-title":"Iron availability and infection","volume":"1790","author":"Weinberg","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbmt.2009.09.011","article-title":"Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy","volume":"16","author":"Busca","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2019.05.036_bib0024","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0268-960X(09)70005-0","article-title":"Impact of iron overload in myelodysplastic syndromes","volume":"23","author":"Fenaux","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0025","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00277-017-3034-6","article-title":"Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT)","volume":"96","author":"Hilken","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0026","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/bmt.2010.108","article-title":"Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation","volume":"46","author":"Kanda","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0027","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2008.11.012","article-title":"Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Kataoka","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156713","article-title":"Chronic iron overload results in impaired bacterial killing of THP-1\u2013derived macrophages through the inhibition of lysosomal acidification","volume":"11","author":"Kao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0029","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2141.1996.d01-1795.x","article-title":"The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload","volume":"94","author":"Jensen","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0030","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1537-2995.2010.02617.x","article-title":"Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients","volume":"50","author":"Oliva","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0031","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3324\/haematol.2011.048546","article-title":"Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes","volume":"97","author":"Gattermann","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0032","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000158631","article-title":"Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis","volume":"120","author":"Messa","year":"2008","journal-title":"Acta Haematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0033","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1200\/JCO.2010.34.1222","article-title":"Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome","volume":"30","author":"List","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0034","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3324\/haematol.2012.077669","article-title":"Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study","volume":"98","author":"Lee","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bmt.2013.213","article-title":"Deferasirox improves hematopoiesis after allogeneic hematopoietic SCT","volume":"49","author":"Visani","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0036","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/10428194.2015.1085530","article-title":"Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia","volume":"57","author":"Olivieri","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0037","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00277-018-3278-9","article-title":"Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"97","author":"Shimomura","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0038","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/bmt.2016.98","article-title":"Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis","volume":"51","author":"Alchalby","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0039","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.2016.146811","article-title":"Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation","volume":"101","author":"Hart","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0609.1983.tb01451.x","article-title":"Influence of the spleen on the distribution of blood neutrophils. Quantitative studies in the rat","volume":"30","author":"Rohrer","year":"1983","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0041","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bmt.2012.249","article-title":"Effects of spleen status on early outcomes after hematopoietic cell transplantation","volume":"48","author":"Akpek","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0042","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bbmt.2017.03.002","article-title":"The impact of splenectomy in myelofibrosis patients before allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Robin","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0043","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12185-016-1940-3","article-title":"Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients","volume":"103","author":"Kitanaka","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0044","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.bbmt.2018.05.023","article-title":"Peritransplantation ruxolitinib prevents acute graft-versus-host disease in patients with myelofibrosis undergoing allogenic stem cell transplantation","volume":"24","author":"Kr\u00f6ger","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.blre.2005.11.002","article-title":"The role of mesenchymal stem cells in haemopoiesis","volume":"20","author":"Dazzi","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0046","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1089\/scd.2009.0029","article-title":"Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study","volume":"18","author":"Meuleman","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0047","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3727\/096368912X661319","article-title":"Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study","volume":"23","author":"Liu","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.bbmt.2019.05.036_bib0048","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bbmt.2018.06.021","article-title":"Dysfunctional bone marrow mesenchymal stem cells in patients with poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Song","year":"2018","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119303611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119303611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:07:56Z","timestamp":1761059276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119303611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1083879119303611"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.05.036","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}